Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage.

Author(s): Nasr A, Shahin AY, Elsamman AM, Zakherah MS, Shaaban OM

Affiliation(s): Department of Obstetrics and Gynecology, Women's Health Center, Assiut University, Assiut, Egypt. a_nasr02@lycos.com

Publication date & source: 2009-06, Int J Gynaecol Obstet., 105(3):244-7. Epub 2009 Feb 26.

Publication type: Comparative Study; Randomized Controlled Trial

OBJECTIVE: To assess the effectiveness of 800 microg of rectal misoprostol compared with an intravenous infusion of 5 IU of oxytocin as prophylaxis against postpartum hemorrhage (PPH). METHODS: A total of 514 women in labor were randomized into two groups (257 women in each). Within 1 minute of delivery of the anterior shoulder participants in group 1 received 800 microg of rectal misoprostol and 1 ampoule of normal saline in 5 mL lactated Ringer solution intravenously; group 2 received a rectal placebo tablet and 5 IU of oxytocin in 5 mL lactated Ringer solution intravenously. RESULTS: Both groups were comparable regarding the need for uterotonics, blood transfusion, and hematocrit drop of 10% or greater, 24 hours post partum (P=0.54, P=0.25, and P=0.85, respectively). Fever was significantly higher among misoprostol patients (18.7% vs 0.8%, P<0.001). CONCLUSIONS: Routine use of 800 microg of rectal misoprostol was effective in reducing blood loss after delivery. We recommend the regimen for low-resource, busy obstetric settings.